NTRANatera, Inc.
$310.78+61% 1Y
$310.78
$182.6552 weeks$436.09
Operating metrics
Tests processed at Natera: 1.09M for Q3 2026, +22% on a year ago.
Operating metrics
From earnings releases, Q3 2021 to Q3 2026
Tests processed, Q3 2026+22% on a year ago1.09M
+22% on a year ago
Tests processed, Q3 2026: 1.09M
Tests processed1,093,100893,600Tests accessioned in our laboratory plus units processed outside of our laboratory
Source: Q3 2026 earnings release, filed Nov 5, 2026Every quarter, with its source
| Quarter | Tests processed | Release |
|---|---|---|
| Q3 2026 | 1.09M | Filed Nov 5, 2026 |
| Q2 2026 | 1.04M | Filed Aug 6, 2026 |
| Q1 2026 | 1.01M | Filed May 7, 2026 |
| Q4 2025 | 924K | Filed Feb 26, 2026 |
| Q3 2025 | 894K | Filed Nov 6, 2025 |
| Q2 2025 | 853K | Filed Aug 7, 2025 |
| Q1 2025 | 855K | Filed May 8, 2025 |
| Q4 2024 | 793K | Filed Feb 27, 2025 |
| Q3 2024 | 776K | Filed Nov 12, 2024 |
| Q2 2024 | 760K | Filed Aug 8, 2024 |
| Q1 2024 | 736K | Filed May 9, 2024 |
| Q4 2023 | 627K | Filed Feb 28, 2024 |
| Q3 2023 | 626K | Filed Nov 8, 2023 |
| Q2 2023 | 617K | Filed Aug 3, 2023 |
| Q1 2023 | 626K | Filed May 9, 2023 |
| Q4 2022 | 560K | Filed Feb 28, 2023 |
| Q3 2022 | 518K | Filed Nov 8, 2022 |
| Q2 2022 | 500K | Filed Aug 4, 2022 |
| Q1 2022 | 489K | Filed May 5, 2022 |
| Q4 2021 | 439K | Filed Feb 24, 2022 |
| Q3 2021 | 407K | Filed Nov 4, 2021 |
- Tests processed
- Tests accessioned in Natera's laboratory plus units processed outside of its laboratory during the quarter.
Source: company earnings releases furnished to the SEC on Form 8-K (Item 2.02, Exhibit 99), SEC EDGAR.
Diagnostics & Research
The closest names by size in the same industry